Back to Browse Journals » Neuropsychiatric Disease and Treatment » Volume 9

Personality disorders and treatment drop out in the homeless

Authors Salavera C, Tricás JM, Lucha O

Published Date March 2013 Volume 2013:9 Pages 379—387


Received 29 September 2012, Accepted 7 December 2012, Published 22 March 2013

Carlos Salavera,1 José M Tricás,2 Orosia Lucha2

1Faculty of Education, University of Zaragoza, Zaragoza, Spain; 2Physiotherapy Research Unit, University of Zaragoza, Zaragoza, Spain

Abstract: The homeless drop out of treatment relatively frequently. Also, prevalence rates of personality disorders are much higher in the homeless group than in the general population. We hypothesize that when both variables coexist – homelessness and personality disorders – the possibility of treatment drop out grows. The aim of this study was to analyze the hypotheses, that is, to study how the existence of personality disorders affects the evolution of and permanence in treatment. One sample of homeless people in a therapeutic community (N = 89) was studied. The structured clinical interview for the diagnostic and statistical manual of mental disorders (DSM-IV-TR) was administered and participants were asked to complete the Millon Clinical Multiaxial Inventory-II (MCMI-II). Cluster B personality disorders (antisocial, borderline, and narcissistic) avoided permanence in the treatment process while cluster C disorders, as dependent, favored adhesion to the treatment and improved the prognosis. Knowledge of these personality characteristics should be used to advocate for better services to support homeless people and prevent their dropping out before completing treatment.

Keywords: MCMI-II, abandonment, personality disorder, homeless

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Other article by this author:

Semantics, pragmatics, and formal thought disorders in people with schizophrenia

Salavera C, Puyuelo M, Antoñanzas JL, Teruel P

Neuropsychiatric Disease and Treatment 2013, 9:177-183

Published Date: 7 February 2013

Readers of this article also read:

Effects of irbesartan on serum uric acid levels in patients with hypertension and diabetes

Nakamura M, Sasai N, Hisatome I, Ichida K

Clinical Pharmacology: Advances and Applications 2014, 6:79-86

Published Date: 3 May 2014

Pharmacokinetics and pharmacodynamics of acetylsalicylic acid after intravenous and oral administration to healthy volunteers

Nagelschmitz J, Blunck M, Kraetzschmar J, Ludwig M, Wensing G, Hohlfeld T

Clinical Pharmacology: Advances and Applications 2014, 6:51-59

Published Date: 19 March 2014

Population pharmacokinetics of olprinone in healthy male volunteers

Kunisawa T, Kasai H, Suda M, Yoshimura M, Sugawara A, Izumi Y, Iida T, Kurosawa A, Iwasaki H

Clinical Pharmacology: Advances and Applications 2014, 6:43-50

Published Date: 4 March 2014

Epilepsy and homicide

Pandya NS, Vrbancic M, Ladino LD, Tellez-Zenteno JF

Neuropsychiatric Disease and Treatment 2013, 9:667-673

Published Date: 14 May 2013

Differences between bipolar and unipolar depression on Rorschach testing

Kimura H, Osaki A, Kawashima R, Inoue T, Nakagawa S, Suzuki K, Asakura S, Tanaka T, Kitaichi Y, Masui T, Kitagawa N, Kako Y, Abekawa T, Kusumi I, Yamanaka H, Denda K, Koyama T

Neuropsychiatric Disease and Treatment 2013, 9:619-627

Published Date: 7 May 2013

Detemir as a once-daily basal insulin in type 2 diabetes

Nelson SE

Clinical Pharmacology: Advances and Applications 2011, 3:27-37

Published Date: 18 August 2011